Poly (lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: In vitro release profile and in vivo tissue distribution

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 11, Issue 4, 2004, Pages 255-261

  Eley, J G ^a   Pujari, V D ^b   McLane, J ^c  

^a PALM BEACH ATLANTIC UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

^c National Pharmacy Care Inc   (United States)

Author keywords

Coumarin 6; Nanoparticles; Poly(Lactide Glycolide)CoPolymer; Suppositories; Sustained Release

Indexed keywords

ACETONE; COUMARIN; COUMARIN 6; FLUORESCENT DYE; MACROGOL; MAGNESIUM ACETATE; MAGNESIUM DERIVATIVE; MANNITYL OLEATE; MOWIOL 4 88; NANOPARTICLE; OLEIC ACID; POLYGLACTIN; POLYMER; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG TISSUE LEVEL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LASER DIFFRACTION; LIPOPHILICITY; LUNG; MALE; MICROSCOPY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SUPPOSITORY; SUSTAINED DRUG RELEASE; SYSTEMIC CIRCULATION;

ANIMALS; COUMARINS; DRUG DELIVERY SYSTEMS; GLYCOLATES; MALE; NANOSTRUCTURES; RABBITS; SUPPOSITORIES; TISSUE DISTRIBUTION;

EID: 4143125874     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540490467384     Document Type: Article

References (10)

1. Allémann, E., Gurny, R., and Doelker, E. 1992. Preparation of aqueous polymeric nanodispensions by a reversible salting-out process: Influence of process parameters on particle size. Int. J. Pharmaceutics 87:247-253.
2. Atkins, T. W., Peacock, S. J., and Yates, D. J. 1998. Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres. J. Microencaps. 15:31-44.
3. Bruero, E., Fainsinger, R., Spachynski, K., Babul, N., Harsanyi, Z., and Darke, A. C. 1995. Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain. J. Clin. Pharmacol 35:666-672.
4. Eley, J. G., and Tirumalasetty, P. P. 2003. Release characteristics of polymethacrylate nanospheres containing coumarin-6. J. Microencaps. 20(5):653-659.
5. Kanke, M., Tanabe, E., Katayama, H., Koda, Y., and Yoshitomi, H. 1995. Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro. Biol. Pharm. Bull. 18(8):1154-1158.
6. Kawashima, S., Inoue, Y., Shimeno, T., and Fujiwara, H. 1990. Studies on sustained-release suppositories. III. Rectal absorption of morphine in rabbits and prolongation of its absorption by alginic acid addition. Chemi. Pharm. Bull. 38(2):498-505.
7. Lombry, C., Bosquillon, C., Preat, V., and Vanbever, R. 2002. Confocal imaging of rat lungs following intratracheal delivery of dry powders or solutions of fluorescent probes. J. Contr. Rel. 83:331-341.
8. Morgan, D. J., McCormick, Y., Cosolo, W., Roller, L., and Zalcbero, J. 1992. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo. Int. J. Clin. Pharmacol. Ther. and Toxicol. 30:576-581.
9. Pavy, T., Medley, C., and Murphy, D. F. 1990. Effect of indomethacin on pain relief after thoracotomy. Br. F. Anaesth. 65:624-627.
10. Pettit, D. K., Lawter. J., Huang, W., Pankey, S., Nightlinger, N., Lynch, D., Schuh, J., Morrissey, P., and Gombotz, W. 1997. Characterization of poly(glycolideco-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF Pharm. Res. 14:1422-1430.